Ann: Appendix 4C and Quarterly Update, page-75

Geez the whole Elanco thing really took the wind out of the sails and I too would love to have some defining clue as to the decisive factors involved. Now theres talk of further sp decline, more unsettling of the resolve to stay with the science. Sh’s screamed for more clarity and timelines, and when that was given, still not content. Like Buffett says, if you’re not willing to ride the highs as well as the lows of a company then you shouldn’t invest in it, or something like that.
The Netherlands is home to Professor Hans Clever, pioneer of Organoid technology who has collaborated with Leiden on more than one occasion,might seem long bow, but with Europe in the grips of third wave if we can back up the earlier tests and have successful organoid results it’ll be gail force winds ahead.
Looking forward to this weeks agm, have decided to keep my faith in the bod and vote yes to all. December around the corner and this thing aint going away anytime soon.
All the best!